[HTML][HTML] Systemic hypertension with VEGFR inhibitor (axitinib) therapy in cancer patients: A meta-analysis and systematic review of randomized controlled trials

AD Babu, S Singh, A Thota, S Duhan… - IJC Heart & …, 2024 - Elsevier
Vascular endothelial growth factor receptor inhibitors (VEGFRi), namely axitinib, are
commonly used chemotherapeutic agents in patients with cancer; however, this medication …